These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 35705961)

  • 1. Private sector engagement in the COVID-19 response: experiences and lessons from the Democratic Republic of Congo, Nigeria, Senegal and Uganda.
    Kabwama SN; Kiwanuka SN; Mapatano MA; Fawole OI; Seck I; Namale A; Ndejjo R; Kizito S; Monje F; Bosonkie M; Egbende L; Bello S; Bamgboye EA; Dairo MD; Adebowale AS; Salawu MM; Afolabi RF; Diallo I; Leye MMM; Ndiaye Y; Fall M; Bassoum O; Alfvén T; Sambisa W; Wanyenze RK
    Global Health; 2022 Jun; 18(1):60. PubMed ID: 35705961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 surveillance in Democratic Republic of Congo, Nigeria, Senegal and Uganda: strengths, weaknesses and key Lessons.
    Fawole OI; Bello S; Adebowale AS; Bamgboye EA; Salawu MM; Afolabi RF; Dairo MD; Namale A; Kiwanuka S; Monje F; Namuhani N; Kabwama S; Kizito S; Ndejjo R; Seck I; Diallo I; Makhtar M; Leye M; Ndiaye Y; Fall M; Bassoum O; Mapatano MA; Bosonkie M; Egbende L; Lazenby S; Wang W; Liu A; Bartlein R; Sambisa W; Wanyenze R
    BMC Public Health; 2023 May; 23(1):835. PubMed ID: 37158897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging community health workers for COVID-19 response in Democratic Republic of Congo, Nigeria, Senegal, and Uganda: roles, barriers, and facilitators.
    Namuhani N; Babirye Z; Monje F; Salawu MM; Bosonkie M; Bello S; Kabwama SN; Egbende L; Bamgboye EA; Tusubira A; Kashiya Y; Kizito S; Afolabi RF; Adebowale AS; Dairo MD; Diallo I; Leye MMM; Ndiaye Y; Fall M; Bassoum O; Seck I; Fawole OI; Mapatano MA; Ndejjo R; Wanyenze RK; Kiwanuka SN
    BMC Prim Care; 2024 Jul; 25(1):269. PubMed ID: 39049006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health workforce incentives and dis-incentives during the COVID-19 pandemic: experiences from Democratic Republic of Congo, Nigeria, Senegal, and Uganda.
    Kiwanuka SN; Babirye Z; Kabwama SN; Tusubira AK; Kizito S; Ndejjo R; Bosonkie M; Egbende L; Bondo B; Mapatano MA; Seck I; Bassoum O; Leye MM; Diallo I; Fawole OI; Bello S; Salawu MM; Bamgboye EA; Dairo MD; Adebowale AS; Afolabi RF; Wanyenze RK
    BMC Health Serv Res; 2024 Apr; 24(1):422. PubMed ID: 38570839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving testing capacity for COVID-19: experiences and lessons from Senegal, Uganda, Nigeria, and the Democratic Republic of Congo.
    Bosonkie M; Egbende L; Namale A; Fawole OI; Seck I; Kizito S; Kaba D; Kiwanuka SN; Diallo I; Bello S; Kabwama SN; Kashiya Y; Monje F; Dairo MD; Bondo B; Namuhani N; Leye MMM; Adebowale AS; Bassoum O; Bamgboye EA; Fall M; Salawu M; Afolabi R; Ndejjo R; Wanyenze RK; Mapatano MA
    Front Public Health; 2023; 11():1202966. PubMed ID: 38045972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread and seasonality of COVID-19 pandemic confirmed cases in sub-Saharan Africa: experience from Democratic Republic of Congo, Nigeria, Senegal, and Uganda.
    Adebowale AS; Afolabi RF; Bello S; Salawu MM; Bamgboye EA; Adeoye I; Dairo MD; Kivumbi B; Wanyana I; Seck I; Diallo I; Leye MMM; Bassoum O; Fall M; Ndejjo R; Kabwama SN; Mapatano MA; Bosonkie M; Egbende L; Namale A; Kizito S; Wanyenze RK; Fawole OI
    BMC Infect Dis; 2023 Mar; 23(1):187. PubMed ID: 36991346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unintended consequences of implementing non-pharmaceutical interventions for the COVID-19 response in Africa: experiences from DRC, Nigeria, Senegal, and Uganda.
    Diallo I; Ndejjo R; Leye MMM; Egbende L; Tusubira A; Bamgboye EA; Fall M; Namuhani N; Bosonkie M; Salawu MM; Ndiaye Y; Kabwama SN; Sougou NM; Bello S; Bassoum O; Babirye Z; Afolabi RF; Gueye T; Kizito S; Adebowale AS; Dairo MD; Sambisa W; Kiwanuka SN; Fawole OI; Mapatano MA; Wanyenze RK; Seck I
    Global Health; 2023 Jun; 19(1):36. PubMed ID: 37280682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015.
    ; Hanson K; Goodman C
    Malar J; 2017 May; 16(1):205. PubMed ID: 28526075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of the Private Sector in the COVID-19 Pandemic: Experiences From Four Health Systems.
    Wallace LJ; Agyepong I; Baral S; Barua D; Das M; Huque R; Joshi D; Mbachu C; Naznin B; Nonvignon J; Ofosu A; Onwujekwe O; Sharma S; Quayyum Z; Ensor T; Elsey H
    Front Public Health; 2022; 10():878225. PubMed ID: 35712320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Contextual Factors in Private Sector Engagement: A Case Study of Private Sector Contribution to COVID-19 Mitigation in Nigeria.
    Okeke C; Eigbiremolen GO; Uzochukwu B; Mbachu C; Onwujekwe O
    Front Public Health; 2022; 10():915330. PubMed ID: 35801254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013.
    ; Mpanya G; Tshefu A; Likwela JL
    Malar J; 2017 Feb; 16(1):94. PubMed ID: 28241832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving toward a common goal via cross-sector collaboration: lessons learned from SARS to COVID-19 in Singapore.
    Kim S; Goh Y; Kang JHB
    Global Health; 2022 Sep; 18(1):82. PubMed ID: 36131348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Private sector initiatives to tackle the burden of COVID-19: experiences from the Nigerian frontline.
    Otu A; Effa E; Umoh V; Maxwell N; Ekpenyong A
    Pan Afr Med J; 2021; 38():233. PubMed ID: 34046138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supporting the nation in crisis: the military health system's role in enhancing public health capacity through public-private partnerships.
    Mani V; Pomer A; Korona-Bailey J; Janvrin M; Coles CL; Schoenfeld AJ; Weissman JS; Koehlmoos TP
    Health Res Policy Syst; 2024 Aug; 22(1):108. PubMed ID: 39143629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of family planning and child health services in the private sector: an equity analysis of 12 DHS surveys.
    Chakraborty NM; Sprockett A
    Int J Equity Health; 2018 Apr; 17(1):50. PubMed ID: 29690902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting to FP2020: Harnessing the private sector to increase modern contraceptive access and choice in Ethiopia, Nigeria, and DRC.
    Riley C; Garfinkel D; Thanel K; Esch K; Workalemahu E; Anyanti J; Mpanya G; Binanga A; Pope J; Longfield K; Bertrand J; Shaw B;
    PLoS One; 2018; 13(2):e0192522. PubMed ID: 29444140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of COVID-19 pandemic on provision of sexual and reproductive health services in primary health facilities in Nigeria: a cross-sectional study.
    Adelekan B; Goldson E; Abubakar Z; Mueller U; Alayande A; Ojogun T; Ntoimo L; Williams B; Muhammed I; Okonofua F
    Reprod Health; 2021 Aug; 18(1):166. PubMed ID: 34348757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the roles of partnerships in enhancing the health systems response to COVID-19 in Nigeria.
    Onyedinma CA; Okeke CC; Onwujekwe O
    BMC Health Serv Res; 2023 Aug; 23(1):863. PubMed ID: 37580694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying a Total Market Lens: Increased IUD Service Delivery Through Complementary Public- and Private-Sector Interventions in 4 Countries.
    White JN; Corker J
    Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S21-32. PubMed ID: 27540122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries.
    ; Newton PN; Hanson K; Goodman C
    Malar J; 2017 May; 16(1):204. PubMed ID: 28539125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.